Opinion

How Russian is it?: A very crude question

  Sunday was the day when European Union regulations prohibiting dealings with Russian state energy companies come into effect. That should trigger a further decline in the volume of crude and refined products bought and traded by European companies, but it won’t bring flows to a halt. Even when, or if, the EU finally imposes sanctions on the purchase of ...

Read More »

US Vice President Harris is breaking a whole lot of ties

Vice President Kamala Harris voted six times to break Senate ties this week. That brings her total to 23 ties broken, a record pace. She’s already third all-time, behind only John C Calhoun (31 from 1825-1832) and John Adams (29 from 1789-1797). What she’s voted on tells an important story about the Senate. None of it has been regular legislation. ...

Read More »

Is Tesco boss’s $3.9m bonus justified?

It’s hard to accept that Tesco Plc boss Ken Murphy deserves the full £3.2 million ($3.9 million) top-up he received in addition to his £1.5 million fixed pay for its last financial year. The award points to a badly designed bonus plan which can pay jumbo rewards on very crude metrics. The one good thing about Murphy’s bonus is that ...

Read More »

Saving the planet is way more important now!

  America needs to build a new and greener energy infrastructure, yet there is a problem standing in the way. Or maybe flying in the way, because that obstacle is birds — and, more generally, the human bias toward the status quo when animal interests are at stake. We have to be more willing to disrupt current animal habitats when ...

Read More »

President Biden should rethink his border plan

With an eye on the midterm elections, Republicans have highlighted a burgeoning crisis at the southern border to attack President Joe Biden’s handling of immigration. The criticism is largely warranted. Biden’s failure to implement a coherent border policy has led to a surge in illegal crossings and caused conservatives to amplify fears of a migrant “invasion.” It’s also making it ...

Read More »

UK food prices increase at fastest pace in a decade

UK food prices are rising at the fastest pace in more than a decade. Britain’s big four supermarkets are trying to pass on their own inflation by charging more. However, they must be careful not to sleepwalk into a crisis — as they did in the wake of the great recession, when they drove customers into the arms of the ...

Read More »

Should SoftBank’s Arm return to UK

London is the underdog to New York in the battle to host Arm Ltd’s return to the stock market. It shouldn’t be. The greatest homegrown UK technology business was listed in London before its purchase by SoftBank Group Corp in 2016. There is no convincing reason to believe Arm would be more successful as a US-listed company. SoftBank is planning ...

Read More »

Technology stocks are in a bear market!

It has been a rough few months for US stocks but even rougher for shares of technology companies. The widely followed and tech-heavy Nasdaq Composite Index is down about 30% since it peaked in November. Investors may be wondering whether tech stocks are a bargain. The answer is no: They’re a lot cheaper but not cheap yet. One way to ...

Read More »

Janet Yellen is right about costs of overturning Roe

  You wouldn’t think a hearing of the Senate Banking Committee would turn into a debate over abortion rights. But overturning Roe vs Wade would have real costs for the US economy, and Treasury Secretary Janet Yellen was entirely correct to note them in a tense and revealing exchange with Senator Tim Scott. Limiting or eliminating access abortion “would have ...

Read More »

Pfizer’s Biohaven deal may open era of ‘pharma M&A’

With biotech stocks in the dumps, investors have been hoping for deals to revive the sector, but lately merger-and-acquisition activity has been anemic. Finally, Pfizer announced it will buy Biohaven Pharmaceutical Holding Company Ltd, a nine-year-old company that makes treatments for migraines, for $11.6 billion. The deal, which gives Pfizer an oral drug already on the market and a nasal ...

Read More »
Send this to a friend